Literature DB >> 1126825

Oxalate retinopathy: an experimental model of a flecked retina.

R Caine, D M Albert, M Lahav, J Bullock.   

Abstract

The clinical picture resembling fundus albipunctatus was seen to develop in rabbits following subcutaneous injection with dibutyl oxalate. On histologic examination, the flecks were found to be due to intracellular accumulation of calcium oxalate in the RPE cells. The clinical and histologic features of this animal model closely resemble the recently described entity of oxalate retinopathy in humans which was seen in the presence of high circulating oxalate levels. It is suggested that the presence of metabolic disorders or toxicity which are known to cause oxalate depositions should be sought in patients with fundus albipunctatus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126825

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  3 in total

Review 1.  Nonproliferative and Proliferative Lesions of the Ratand Mouse Special Sense Organs(Ocular [eye and glands], Olfactory and Otic).

Authors:  Meg Ferrell Ramos; Julia Baker; Elke-Astrid Atzpodien; Ute Bach; Jacqueline Brassard; James Cartwright; Cynthia Farman; Cindy Fishman; Matt Jacobsen; Ursula Junker-Walker; Frieke Kuper; Maria Cecilia Rey Moreno; Susanne Rittinghausen; Ken Schafer; Kohji Tanaka; Leandro Teixeira; Katsuhiko Yoshizawa; Hui Zhang
Journal:  J Toxicol Pathol       Date:  2018-07-28       Impact factor: 1.628

2.  Experimentally induced calcium oxalate keratopathy in rabbits.

Authors:  U Weber; H U Sons; W Lenz; H Bernsmeier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Experimental calcium oxalate retinopathy compared with cystine- and tyrosine-induced retinal damage. An ophthalmoscopical, histological, and electrophysiological study.

Authors:  U Weber; H U Sons; R Hennekes; W Lenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.